Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System
An erratum to this article was published (J Diabetes Sci Technol, Jan 2025 ↗)
Methodological details3 virtual consensus meetings of clinicians and researchers (January 17, 2024, April 24, 2024, August 14, 2024)
- 3 virtual consensus meetings of clinicians and researchers (January 17, 2024, April 24, 2024, August 14, 2024)
Recommendations
As issued by the authors
Panelists voted in favor of 31 recommendations
In adults with T1D using automated insulin delivery (AID) systems, GLP-1 RAs have the potential to provide effective adjunct therapy and improve glycemic and metabolic outcomes without increasing the risk of severe hypoglycemia or DKA
Original publication
Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System. J Diabetes Sci Technol. Published 8 November 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →